CN101791438B - 骨修复用生物活性聚(乳酸-羟基乙酸)/胶原/羟基磷灰石复合纤维膜的制备方法 - Google Patents
骨修复用生物活性聚(乳酸-羟基乙酸)/胶原/羟基磷灰石复合纤维膜的制备方法 Download PDFInfo
- Publication number
- CN101791438B CN101791438B CN 201010125478 CN201010125478A CN101791438B CN 101791438 B CN101791438 B CN 101791438B CN 201010125478 CN201010125478 CN 201010125478 CN 201010125478 A CN201010125478 A CN 201010125478A CN 101791438 B CN101791438 B CN 101791438B
- Authority
- CN
- China
- Prior art keywords
- plga
- collagen
- fiber membrane
- membrane
- mineralising
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 152
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 title claims abstract description 137
- 102000008186 Collagen Human genes 0.000 title claims abstract description 106
- 108010035532 Collagen Proteins 0.000 title claims abstract description 106
- 229920001436 collagen Polymers 0.000 title claims abstract description 106
- 239000000835 fiber Substances 0.000 title claims abstract description 102
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 53
- 239000002131 composite material Substances 0.000 title claims abstract description 48
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 36
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000008439 repair process Effects 0.000 title abstract description 5
- 230000000975 bioactive effect Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 claims abstract description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 17
- 230000004071 biological effect Effects 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000012890 simulated body fluid Substances 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 238000001523 electrospinning Methods 0.000 claims description 6
- 238000010041 electrostatic spinning Methods 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000005696 Diammonium phosphate Substances 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 239000007983 Tris buffer Substances 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 4
- 229910000388 diammonium phosphate Inorganic materials 0.000 claims description 4
- 235000019838 diammonium phosphate Nutrition 0.000 claims description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract description 12
- 230000002308 calcification Effects 0.000 abstract description 10
- 210000000963 osteoblast Anatomy 0.000 abstract description 10
- 239000011248 coating agent Substances 0.000 abstract description 8
- 238000000576 coating method Methods 0.000 abstract description 8
- 238000000151 deposition Methods 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 7
- 239000002121 nanofiber Substances 0.000 abstract description 7
- 210000004409 osteocyte Anatomy 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 238000009832 plasma treatment Methods 0.000 abstract description 5
- 230000011164 ossification Effects 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 18
- 239000001963 growth medium Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- 238000004113 cell culture Methods 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 238000004088 simulation Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 5
- 239000004568 cement Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000035479 physiological effects, processes and functions Effects 0.000 description 4
- 238000001338 self-assembly Methods 0.000 description 4
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004072 osteoblast differentiation Effects 0.000 description 3
- 230000001582 osteoblastic effect Effects 0.000 description 3
- JKYKXTRKURYNGW-UHFFFAOYSA-N 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=C(O)C(S(O)(=O)=O)=C2 JKYKXTRKURYNGW-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010061363 Skeletal injury Diseases 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 208000025978 Athletic injury Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000012227 artificial bone substitute Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002524 electron diffraction data Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002367 phosphate rock Substances 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001814 protein method Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010125478 CN101791438B (zh) | 2010-03-16 | 2010-03-16 | 骨修复用生物活性聚(乳酸-羟基乙酸)/胶原/羟基磷灰石复合纤维膜的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010125478 CN101791438B (zh) | 2010-03-16 | 2010-03-16 | 骨修复用生物活性聚(乳酸-羟基乙酸)/胶原/羟基磷灰石复合纤维膜的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101791438A CN101791438A (zh) | 2010-08-04 |
CN101791438B true CN101791438B (zh) | 2013-02-27 |
Family
ID=42584490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010125478 Active CN101791438B (zh) | 2010-03-16 | 2010-03-16 | 骨修复用生物活性聚(乳酸-羟基乙酸)/胶原/羟基磷灰石复合纤维膜的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101791438B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102205149B (zh) * | 2011-05-10 | 2013-10-02 | 中国科学院合肥物质科学研究院 | 羟基磷灰石/壳聚糖/聚乳酸复合骨修复材料及制备方法 |
DK2734106T3 (da) * | 2011-07-22 | 2020-01-06 | Kpr Us Llc | Ekg-elektrodekonnektor |
CN102532573B (zh) * | 2012-02-20 | 2013-10-16 | 浙江大学 | 一种丝胶蛋白/羟基磷灰石复合膜的快速成型方法 |
CN103110979B (zh) * | 2013-02-09 | 2015-06-17 | 复旦大学 | 表面沉积类骨磷灰石的高分子多孔材料及其制备方法和应用 |
CN103251983B (zh) * | 2013-05-10 | 2014-09-17 | 同济大学 | 一种具有治疗作用的拼接式人工骨填充缓释材料的制备方法 |
CN103668940B (zh) * | 2013-12-18 | 2016-08-17 | 华东理工大学 | 一种表面改性纤维增强复合骨水泥及其制备方法和应用 |
CN103785059B (zh) * | 2014-01-03 | 2015-12-02 | 朱小龙 | 一种骨修复再生材料及其制备方法 |
CN104695205B (zh) * | 2015-03-16 | 2017-02-22 | 苏州景卓生物技术有限公司 | 胶原纤维膜制备方法及其应用 |
CN107952115B (zh) * | 2016-10-17 | 2021-10-26 | 北京湃生生物科技有限公司 | 一种仿生生物矿化人工骨修复材料及其制备方法与应用 |
CN107982575A (zh) * | 2017-11-28 | 2018-05-04 | 上海纳米技术及应用国家工程研究中心有限公司 | Ldi-pclla-peg-pclla/羟基磷灰石电纺纤维膜的制法及其产品和应用 |
CN109453426A (zh) * | 2018-09-03 | 2019-03-12 | 北京化工大学 | 一种骨修复用生物活性陶瓷纤维复合支架及其制备方法 |
CN112494463B (zh) * | 2020-11-23 | 2022-10-18 | 潍坊医学院 | 一种小檗碱/矿化胶原复合膜及其制备方法和应用 |
CN113332497B (zh) * | 2021-04-30 | 2022-04-22 | 国家纳米科学中心 | 一种双面支架及其制备方法和应用 |
CN113304318B (zh) * | 2021-06-08 | 2022-05-31 | 同济大学 | 基于仿生矿化的非晶-结晶磷酸钙复合材料及其制备方法和应用 |
CN114949364B (zh) * | 2022-05-30 | 2022-12-27 | 四川大学 | 一种多层组织工程化仿生骨膜支架及制备方法和应用 |
CN115748239B (zh) * | 2022-12-08 | 2024-05-14 | 山东大学 | 一种高强度和柔性羟基磷灰石包覆的二氧化硅复合纤维膜的制备方法 |
CN117752859A (zh) * | 2023-12-22 | 2024-03-26 | 延边优联农业科技发展有限公司 | 干细胞爬层可降解支架及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003071991A1 (en) * | 1995-10-16 | 2003-09-04 | Depuy Acromed, Inc. | Tissue repair matrix |
CN101007183A (zh) * | 2006-12-01 | 2007-08-01 | 华南理工大学 | 一种原位成孔自固化磷酸钙复合组织工程支架的制备方法 |
CN101584885A (zh) * | 2009-06-25 | 2009-11-25 | 同济大学 | 具有梯度的三层引导组织再生膜的制备方法 |
-
2010
- 2010-03-16 CN CN 201010125478 patent/CN101791438B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003071991A1 (en) * | 1995-10-16 | 2003-09-04 | Depuy Acromed, Inc. | Tissue repair matrix |
CN101007183A (zh) * | 2006-12-01 | 2007-08-01 | 华南理工大学 | 一种原位成孔自固化磷酸钙复合组织工程支架的制备方法 |
CN101584885A (zh) * | 2009-06-25 | 2009-11-25 | 同济大学 | 具有梯度的三层引导组织再生膜的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101791438A (zh) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101791438B (zh) | 骨修复用生物活性聚(乳酸-羟基乙酸)/胶原/羟基磷灰石复合纤维膜的制备方法 | |
CN103041450B (zh) | 用于修复周围神经损伤的细胞基质修饰的组织工程神经移植物及其制备方法 | |
JP6140240B2 (ja) | 組織工学的に作製された絹製臓器 | |
CN101693126B (zh) | 骨修复用聚(乳酸-羟基乙酸)/羟基磷灰石纳米纤维复合支架的制备方法 | |
CN101433478B (zh) | 一种全层生物角膜及其构建方法和用途 | |
CN102294049B (zh) | 生物活性玻璃与壳聚糖复合骨修复材料及其制法和用途 | |
Lin et al. | In vitro and in vivo evaluation of the developed PLGA/HAp/Zein scaffolds for bone-cartilage interface regeneration | |
CN110772669A (zh) | 一种用于3d打印人工皮肤的生物墨水 | |
CN105521525B (zh) | 一种骨组织工程用多孔复合支架及其制备方法 | |
CN102886068A (zh) | 一种plga纳米纤维支架的制备及其在组织工程中的应用 | |
CN107349475B (zh) | 纳米纤维膜与干细胞层层叠加的人工组织工程皮肤及其制备方法 | |
CN104263698B (zh) | 临床治疗级细胞治疗用成纤维细胞规模化制备人类细胞外基质筛选培养方法 | |
CN105688274A (zh) | 一种聚己内酯/明胶电纺复合支架的制备工艺 | |
CN107213529A (zh) | 一种用于提高成骨细胞粘附和成骨性能的可降解医用高分子三维材料的制备方法 | |
CN107137763A (zh) | 一种血管化组织工程骨及其制备方法 | |
CN1846793B (zh) | 一种组织工程骨及其构建与应用 | |
CN109248343A (zh) | 一种自组装多肽水凝胶支架及其制备方法 | |
Hashemi et al. | Osteogenic differentiation of induced pluripotent stem cells on electrospun nanofibers: a review of literature | |
CN101564555A (zh) | 一种组织工程骨移植物及其构建方法 | |
CN104874024B (zh) | 细胞组装小肠黏膜下层仿生复合工程骨及其制备方法 | |
US20160136330A1 (en) | Three-Dimensional Scaffold Functionalized with Micro-Tissues for Tissue Regeneration | |
KR101655333B1 (ko) | 표면개질된 생체적합성 실크피브로인 필름과 그 제조방법 | |
CN101628127A (zh) | 一种眼眶缘组织工程骨及其应用 | |
Zhang et al. | Osteogenesis of Human iPSC‐Derived MSCs by PLLA/SF Nanofiber Scaffolds Loaded with Extracellular Matrix | |
Wani et al. | Nanofiber-mediated stem cell osteogenesis: Prospects in bone tissue regeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WUXI BIOT BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHEJIANG UNIVERSITY Effective date: 20130419 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310027 HANGZHOU, ZHEJIANG PROVINCE TO: 214000 WUXI, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130419 Address after: 214000, Mashan biological pharmaceutical industry park (Ziyun Road), Binhu District, Jiangsu, Wuxi Province Patentee after: Wuxi Biot Bio-technology Co., Ltd. Address before: 310027 Hangzhou, Zhejiang Province, Xihu District, Zhejiang Road, No. 38, No. Patentee before: Zhejiang University |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 214000, Jiangsu, Wuxi province Mashan biological medicine industry park (business place, Wuxi, Binhu District, Mashan, Mei Liang Road, No. 132) Patentee after: Wuxi Betty biological engineering Limited by Share Ltd Address before: 214000, Mashan biological pharmaceutical industry park (Ziyun Road), Binhu District, Jiangsu, Wuxi Province Patentee before: Wuxi Biot Bio-technology Co., Ltd. |